Home  >  Products  >  KRT4 (keratin 4 ) Blocking Peptide (the N terminal of KRT4)(100ug)
KRT4 (keratin 4 ) Blocking Peptide (the N terminal of KRT4)(100ug)

KRT4 (keratin 4 ) Blocking Peptide (the N terminal of KRT4)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KRT4 Antibody (ARP64964_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64964
Size: 100ug
Weight: 56kDa
Gene: 3851
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in differentiated layers of the mucosal and esophageal epithelia with family member KRT13. Mutations in these genes have been associated with White Sponge Nevus, characterized by oral, esophageal, and anal leukoplakia. The type II cytokeratins are clustered in a region of chromosome 12q12-q13.
Alternative names: CK4; CYK4; FLJ31692; K4